WO2015146398A1 - デオドラント組成物及びデオドラント剤 - Google Patents
デオドラント組成物及びデオドラント剤 Download PDFInfo
- Publication number
- WO2015146398A1 WO2015146398A1 PCT/JP2015/054802 JP2015054802W WO2015146398A1 WO 2015146398 A1 WO2015146398 A1 WO 2015146398A1 JP 2015054802 W JP2015054802 W JP 2015054802W WO 2015146398 A1 WO2015146398 A1 WO 2015146398A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- deodorant composition
- deodorant
- mass
- composition according
- ester compound
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/731—Cellulose; Quaternized cellulose derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/26—Aluminium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/27—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/31—Hydrocarbons
- A61K8/315—Halogenated hydrocarbons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/347—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/35—Ketones, e.g. benzophenone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/368—Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
- A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/39—Derivatives containing from 2 to 10 oxyalkylene groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/41—Amines
- A61K8/416—Quaternary ammonium compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q15/00—Anti-perspirants or body deodorants
Definitions
- the present invention relates to a deodorant composition containing a bactericide. Moreover, this invention relates to the deodorant agent with which the said deodorant composition is filled in the container.
- deodorant compositions have been used to prevent this unpleasant odor.
- the said deodorant composition is filled in the container, and is used as a deodorant agent.
- the deodorant is used in various types such as gels, creams, lotions, aerosol sprays, mists and sticks.
- the roll-on type deodorant agent is excellent in usability because the composition can be directly and uniformly applied to the application object without attaching the composition to the application object. Furthermore, a roll-on type deodorant agent is preferable because it has a high adhesiveness to the contents, and thus easily exhibits a higher odor prevention effect than an aerosol type deodorant agent. For this reason, in recent years, the usage rate of a roll-on type deodorant agent is increasing among the deodorant agents.
- Patent Document 1 discloses a deodorant composition containing a hydroxyalkylated cyclodextrin, an antiperspirant active ingredient, and water. Patent Document 1 describes that it is possible to provide a deodorant composition having a deodorizing effect and a long-lasting power that are not available in the past.
- Patent Document 2 discloses a deodorant composition
- a deodorant composition comprising (A) an antiperspirant and / or bactericidal agent, (B) an unsaturated fatty acid, (C) an antioxidant, and (D) an aqueous medium.
- Patent Document 2 describes that it is possible to provide a deodorant agent that has excellent quick-drying properties on the skin, is easy to handle, and has little irritation.
- Patent Document 3 listed below includes (A) 0.05 to 5.0% by weight of chloromethacrylic acid choline ester copolymer, (B) 10.0 to 50.0% by weight of ethanol, and (C) sulfococolic acid.
- Deodorant compositions containing 0.5 to 3.0 wt% zinc and / or 0.5 to 10.0 wt% aluminum hydroxychloride are disclosed.
- Patent Document 3 describes that a deodorant effect with less irritation and good feel is achieved.
- an object of the present invention is to provide a deodorant composition capable of dramatically increasing the persistence of a bactericidal agent to an application target after application, and to provide a deodorant agent using the deodorant composition. It is.
- the present invention provides a deodorant composition
- a deodorant composition comprising ethanol, a bactericide, a hydrophobized hydroxyalkyl cellulose, and an ester compound having a molecular weight of 150 or more.
- the log P value of the ester compound is preferably 1 or more and 40 or less.
- ester compound isononyl isononanoate, glyceryl tri-2-ethylhexanoate, diisopropyl adipate, diisobutyl adipate, polypropylene glycol-3benzyl ether myristate, isopropyl myristate, propylene glycol isostearate, isopropyl palmitate, palmitate 2
- It is preferably an ester compound selected from the group consisting of ethylhexyl, cetyl 2-ethylhexanoate, pentaerythrityl tetraoctanoate, octyldodecyl myristate, and pentaerythritol tetraisostearate.
- the fungicide is a fungicide selected from the group consisting of isopropylmethylphenol, benzalkonium chloride, hinokitiol, triclosan, and salicylic acid.
- the deodorant composition according to the present invention preferably contains a nonionic surfactant.
- the deodorant composition according to the present invention preferably contains an antiperspirant.
- the antiperspirant is an antiperspirant selected from the group consisting of chlorohydroxyaluminum, zinc paraphenolsulfonate, and alum.
- the present invention also provides a deodorant agent comprising a container and the above-described deodorant composition, wherein the deodorant composition is filled in the container.
- the deodorant according to the present invention is preferably a non-aerosol formulation.
- the deodorant composition according to the present invention contains ethanol, a bactericide, a hydrophobized hydroxyalkyl cellulose, and an ester compound having a molecular weight of 150 or more.
- the hydrophobized hydroxyalkyl cellulose and the ester compound having a molecular weight of 150 or more are used in combination. Can do.
- the deodorant composition according to the present invention includes at least ethanol, a bactericide, a hydrophobized hydroxyalkyl cellulose, and an ester compound having a molecular weight of 150 or more.
- the ethanol is “(A) ethanol” or “component (A)”; the bactericidal agent is “(B) bactericidal agent” or “component (B)”; the hydrophobized hydroxyalkyl cellulose.
- “(C) Hydrophobized hydroxyalkyl cellulose” or “component (C)”; the ester compound having a molecular weight of 150 or more is referred to as “(D) an ester compound having a molecular weight of 150 or more”, “(D) ester compound”. Alternatively, it may be referred to as “component (D)”.
- a component to be blended with (A) ethanol and (B) a fungicide as a component to be blended with (A) ethanol and (B) a fungicide, (C) a hydrophobized hydroxyalkyl cellulose and (D) an ester compound having a molecular weight of 150 or more are used in combination.
- the persistence of the (B) bactericidal agent in the application object such as a basket can be dramatically increased. For this reason, even if time passes after application
- the deodorant composition according to the present invention preferably contains a nonionic surfactant.
- the deodorant composition according to the present invention may contain an antiperspirant. Thereby, the effect as a deodorant composition can be improved further.
- nonionic surfactant is referred to as “(E) nonionic surfactant” or “component (E)”; the antiperspirant as “(F) antiperspirant” or “component ( F) ".
- the deodorant composition according to the present invention preferably contains water from the viewpoint of more effectively expressing the effect of the component (C). Furthermore, the deodorant composition according to the present invention may contain components other than the components (A) to (F) and water.
- each of the components contained in the deodorant composition according to the present invention that is, the components (A) to (F), water and other components may be used alone or in combination of two or more. Also good.
- the content of (A) ethanol in the deodorant composition according to the present invention is not particularly limited. In 100% by mass of the deodorant composition, the content of (A) ethanol is preferably 20.0% by mass or more, more preferably 40.0% by mass or more, still more preferably more than 50.0% by mass, particularly preferably. 60.0% by mass or more, preferably 99.5% by mass or less, more preferably 95.5% by mass or less, further preferably 90.0% by mass or less, particularly preferably 89.0% by mass or less, and most preferably 80 0.0 mass% or less.
- (A) Usability and quick-drying property become still higher that content of ethanol is more than the above-mentioned minimum.
- the upper limit of content of ethanol can be suitably adjusted according to content of another component.
- the (B) bactericidal agent contained in the deodorant composition according to the present invention has a bactericidal action.
- coating are quite excellent.
- bactericidal agent examples include isopropylmethylphenol, benzalkonium chloride, hinokitiol, triclosan, salicylic acid, and the like.
- a disinfectant only 1 type may be used and 2 or more types may be used.
- the bactericidal agent is isopropylmethylphenol, benzalkonium chloride, hinokitiol, triclosan, And a fungicide selected from the group consisting of salicylic acid (at least one fungicide), and a fungicide selected from the group consisting of isopropylmethylphenol, benzalkonium chloride, and hinokitiol (at least one fungicide) ) Is more preferable.
- the content of the (B) fungicide in the deodorant composition according to the present invention is not particularly limited. In 100% by mass of the deodorant composition, the content of the (B) bactericide is preferably 0.01% by mass or more, more preferably 0.05% by mass or more, preferably 2.0% by mass or less, more preferably 1%. 0.0 mass% or less, more preferably 0.5 mass% or less. (B) If the content of the bactericidal agent is not less than the above lower limit, the bactericidal effect can be obtained more effectively. Moreover, it is preferable that content of (B) bactericide is below the said upper limit from a viewpoint of improving safety
- the (C) hydrophobized hydroxyalkyl cellulose contained in the deodorant composition according to the present invention is a hydrophobized product of hydroxyalkyl cellulose.
- Hydrophobized hydroxyalkyl cellulose is not particularly limited. Examples of (C) hydrophobized hydroxyalkylcellulose include hydrophobized hydroxypropylmethylcellulose and hydrophobized hydroxyethylcellulose.
- As for the hydrophobized hydroxyalkyl cellulose only 1 type may be used and 2 or more types may be used.
- (C) Hydrophobized hydroxyalkyl cellulose is preferably obtained by introducing an alkyl group into hydroxyalkyl cellulose.
- the hydrophobized hydroxypropylmethylcellulose is preferably obtained by introducing an alkyl group into hydroxypropylmethylcellulose.
- the alkyl group is preferably a long-chain alkyl group. Since the hydrophobicity is high, the (C) hydrophobized hydroxyalkyl cellulose is preferably obtained by introducing an alkyl group having 12 or more carbon atoms (an alkyl group that imparts hydrophobicity) into the hydroxyalkyl cellulose.
- the hydrophobized hydroxyalkyl cellulose preferably has an alkyl group having 12 or more carbon atoms (an alkyl group that imparts hydrophobicity).
- the upper limit of the carbon number of the alkyl group that imparts hydrophobicity is not particularly limited.
- the alkyl group that imparts hydrophobicity preferably has 22 or less carbon atoms.
- the alkyl group imparting hydrophobicity may be linear or branched.
- the straight chain portion of the alkyl group that imparts hydrophobicity preferably has 12 or more carbon atoms.
- hydrophobic alkyl group examples include dodecyl, tridecyl, tetradecyl, pentadecyl, hexadecyl, heptadecyl, octadecyl, nonadecyl, eicosyl, heneicosyl, and docosyl groups.
- Hydrophobized hydroxyalkyl cellulose is preferably alkyloxyhydroxyalkyl cellulose.
- the hydrophobized hydroxypropylmethylcellulose is preferably alkyloxyhydroxypropylmethylcellulose.
- the carbon number of the alkyloxy group in the alkyloxyhydroxyalkyl cellulose is preferably 12 or more, and preferably 22 or less.
- Hydrophobized hydroxyalkyl cellulose may have a group containing an alkyl group (such as a long-chain alkyl group) that imparts hydrophobicity that is not the above-mentioned alkyloxy group.
- alkyloxy group examples include dodecyloxy group (lauroxy group), tridecyloxy group, tetradecyloxy group (myristyloxy group), pentadecyloxy group, hexadecyloxy group (cetyloxy group), heptadecyloxy group, octadecyloxy group (stearoxy group) , Nonadecyloxy group, eicosyloxy group, heneicosyloxy group, docosyloxy group and the like.
- Examples of (C) hydrophobized hydroxyalkylcellulose include dodecyloxyhydroxyalkylcellulose (lauroxyhydroxyalkylcellulose), tridecyloxyhydroxyalkylcellulose, tetradecyloxyhydroxyalkylcellulose (myristyloxyhydroxyalkylcellulose), pentade Siloxyhydroxyalkylcellulose, hexadecyloxyhydroxyalkylcellulose (cetyloxyhydroxyalkylcellulose), heptadecyloxyhydroxyalkylcellulose, octadecyloxyhydroxyalkylcellulose (stearoxyhydroxyalkylcellulose), nonadesiloxyhydroxyalkylcellulose, eicosiloxyhydroxy Alkylcellulose, henecosyloxyhydroxy Le Kill cellulose and DoCoMo siloxy hydroxyalkyl cellulose.
- the hydrophobized hydroxyalkyl cellulose is particularly preferably octadecyloxyhydroxyalkylcellulose (stearoxyhydroxyalkylcellulose), and most preferably octadecyloxyhydroxypropylmethylcellulose (stearoxyhydroxypropylmethylcellulose). .
- hydrophobized hydroxyalkyl cellulose A commercially available product may be used as the hydrophobized hydroxyalkyl cellulose.
- Examples of commercially available hydrophobized hydroxyalkyl cellulose include Sangelose 60L, Sangelose 60M, Sangerose 90L, Sangerose 90M (trade names: all stearoxyhydroxypropylmethylcellulose, manufactured by Daido Kasei Kogyo Co., Ltd.). It is done.
- the content of (C) hydrophobized hydroxyalkyl cellulose in the deodorant composition according to the present invention is not particularly limited. In 100% by mass of the deodorant composition, the content of (C) the hydrophobized hydroxyalkyl cellulose is preferably 0.3% by mass or more, more preferably 0.5% by mass or more, and preferably 5.0% by mass or less. Preferably it is 3.0 mass% or less.
- the content of the hydrophobized hydroxyalkyl cellulose is not less than the above lower limit, the persistence of the bactericidal agent after coating and the durability of the bactericidal effect after coating are more effectively increased.
- ((D) ester compound having a molecular weight of 150 or more) The molecular weight of the (D) ester compound contained in the deodorant composition according to the present invention is 150 or more.
- (D) When the molecular weight of the ester compound is not less than the above lower limit, the persistence of the bactericide after coating and the durability of the bactericidal effect after coating are effectively increased.
- the log P value of the (D) ester compound is preferably 40 or less, more preferably Is 20 or less, more preferably 10 or less.
- the log P value of the (D) ester compound is preferably 1 or more, more preferably 2 or more.
- the logP value is a value calculated based on the database “ChemSpider”.
- the ester compound is isononyl isononanoate, glyceryl tri-2-ethylhexanoate, adipic acid Diisopropyl, diisobutyl adipate, polypropylene glycol-3benzyl ether myristate, isopropyl myristate, propylene glycol isostearate, isopropyl palmitate, 2-ethylhexyl palmitate, cetyl 2-ethylhexanoate, pentaerythrityl tetraoctanoate, myristic acid It is preferably an ester compound (at least one ester compound) selected from the group consisting of octyldodecyl and pentaerythritol tetraisostearate.
- the ester compound is isononyl isononanoate, glyceryl tri-2-ethylhexanoate, adipic acid It is preferably an ester compound (at least one ester compound) selected from the group consisting of diisopropyl, polypropylene glycol-3 myristate-3benzyl ether, isopropyl myristate, propylene glycol isostearate, and isopropyl palmitate.
- the molecular weight of the (D) ester compound is preferably 180 or more, more preferably 200 or more, preferably 5000. Hereinafter, more preferably 2000 or less, and still more preferably 600 or less.
- the content of the (D) ester compound in the deodorant composition according to the present invention is not particularly limited. In 100% by mass of the deodorant composition, the content of the (D) ester compound is preferably 0.1% by mass or more, more preferably 0.3% by mass or more, preferably 10.0% by mass or less, more preferably 5%. 0.0 mass% or less.
- content of an ester compound is more than the said minimum, the persistence of the bactericide after application
- Usability and quick-drying property become still more favorable that content of an ester compound is below the said upper limit.
- the deodorant composition according to the present invention preferably contains (E) a nonionic surfactant.
- the (E) nonionic surfactant also acts as a solubilizer for the (D) ester compound and plays a role of further enhancing the effect of adding the (D) ester compound.
- Nonionic surfactant is not particularly limited.
- sorbitan fatty acid ester glycerin fatty acid ester, polyglycerin fatty acid ester, polyoxyalkylene alkyl ether, polyoxyalkylene fatty acid ester, polyoxyalkylene sorbitan fatty acid ester
- examples include polyoxyalkylene castor oil, polyoxyalkylene hydrogenated castor oil, sucrose fatty acid ester, alkyl polyglucoside, and polyoxyethylene lanolin.
- nonionic surfactant only 1 type may be used and 2 or more types may be used.
- the content of (E) nonionic surfactant in the deodorant composition according to the present invention is not particularly limited. In 100% by mass of the deodorant composition, the content of (E) nonionic surfactant is preferably 0.01% by mass or more, more preferably 0.1% by mass or more, and preferably 10.0% by mass or less. Preferably it is 5.0 mass% or less.
- content of nonionic surfactant is more than the said minimum, the persistence of the bactericidal agent after application
- content of nonionic surfactant is below the said upper limit, usability and quick-drying property will become still better.
- the deodorant composition according to the present invention may include (F) an antiperspirant.
- the antiperspirant suppresses the generation of sweat, for example, by converging the skin.
- the antiperspirant is not particularly limited.
- As an antiperspirant a conventionally well-known antiperspirant is mentioned.
- As for an antiperspirant only 1 type may be used and 2 or more types may be used.
- antiperspirants include aluminum salts and zinc paraphenolsulfonate.
- examples of the aluminum salt include aluminum chloride, aluminum sulfate, potassium aluminum sulfate (potassium alum), aluminum ammonium sulfate (ammonium alum), aluminum acetate, chlorohydroxyaluminum, and allantochlorohydroxyaluminum.
- Other antiperspirants may be used.
- the antiperspirant is preferably at least one of an aluminum salt and zinc paraphenolsulfonate, such as chlorohydroxyaluminum, zinc paraphenolsulfonate, and alum. More preferred is an antiperspirant selected from the group consisting of (at least one antiperspirant), and an antiperspirant selected from the group consisting of chlorohydroxyaluminum, zinc paraphenolsulfonate and potassium aluminum sulfate (at least 1) is more preferred.
- the content of (F) antiperspirant in the deodorant composition according to the present invention is not particularly limited.
- the content of the (F) antiperspirant is preferably 0.01% by mass or more, more preferably from the viewpoint of improving the antiperspirant effect, usability and safety. 1 mass% or more, preferably 25.0 mass% or less, more preferably 20.0 mass% or less.
- the deodorant composition according to the present invention preferably contains water.
- the water is not particularly limited, but is preferably purified water.
- the hydrophobized hydroxyalkyl cellulose swells and the effect is more easily exhibited.
- the content of water is preferably 5.0% by mass or more, more preferably 10.0% by mass or more, preferably 45.0% by mass or less, more preferably 30.0% by mass. It is as follows.
- the deodorant composition according to the present invention may contain a thickener.
- the thickener include water-soluble polymers.
- Specific examples of the thickener include hydroxyalkyl cellulose.
- Examples of the hydroxyalkylcellulose include hydroxymethylcellulose, hydroxyethylcellulose, hydroxypropylcellulose, and hydroxypropylmethylcellulose.
- the said thickener only 1 type may be used and 2 or more types may be used.
- the deodorant agent or components usually used in cosmetics may be added to the deodorant composition according to the present invention.
- the deodorant composition according to the present invention includes, for example, (E) a surfactant other than a nonionic surfactant, a moisturizer, a deodorant, an oil component, a sequestering agent, an antiseptic, a refreshing agent, an anti-inflammatory agent, Plant extracts and flavors may be included.
- the surfactants other than the above (E) nonionic surfactants include anionic surfactants, amphoteric surfactants, and cationic surfactants.
- examples of the humectant include sorbitol. Glycerin can also be used as a humectant.
- examples of the oil component include hydrocarbons and silicone.
- the viscosity ⁇ at 25 ° C. of the deodorant composition according to the present invention is not particularly limited, but is preferably 10 mPa ⁇ s or more, more preferably 50 mPa, from the viewpoint of improving the dischargeability and applicability of the deodorant composition from the container. S or more, preferably 5000 mPa ⁇ s or less, more preferably 3000 mPa ⁇ s or less.
- the viscosity ⁇ is not particularly limited, but can be measured using, for example, a B-type viscometer.
- a B-type viscometer for example, using an L adapter, conditions of 25 ° C. and 12 rpm, rotor No. 2 at 25 ° C. and 30 rpm, or rotor no. 3 is used and the viscosity is measured at 25 ° C. and 30 rpm.
- the B-type viscometer "TV-20" manufactured by Toki Sangyo Co., Ltd. can be used.
- the deodorant agent according to the present invention includes a container and the deodorant composition filled in the container.
- the container examples include a roll-on container, a spray container (aerosol type, non-aerosol type), and a tube container.
- the container is preferably a roll-on container.
- the composition can be directly and uniformly applied to the application object without attaching the composition to the application object. That is, the roll-on container is excellent in applicability. For example, it is easy to directly apply the deodorant composition in a roll-on container to skin such as wrinkles.
- the roll-on type deodorant agent the effect of increasing the persistence of the sterilizing agent after application and the sustainability of the sterilizing effect after application is more easily exhibited.
- the roll-on container includes a roll in the application unit.
- the roll may be a cylindrical member or a spherical member.
- the deodorant composition according to the present invention is preferably applied to the skin and is preferably applied to the eyelid.
- the deodorant composition according to the present invention is preferably a skin deodorant composition, and preferably a vaginal deodorant composition.
- the deodorant composition according to the present invention may be applied to skin other than wrinkles.
- the deodorant according to the present invention is preferably used by applying the composition to the skin, and is preferably used by applying the composition to the eyelid.
- the deodorant according to the present invention is preferably a skin deodorant, and preferably a vaginal deodorant.
- the deodorant according to the present invention may be an aerosol formulation or a non-aerosol formulation.
- the deodorant according to the present invention is preferably a non-aerosol preparation because the effect of enhancing the persistence of the bactericidal agent after application and the durability of the bactericidal effect after application is more easily exhibited.
- the dosage form of the deodorant according to the present invention is not particularly limited, and examples thereof include roll-on, mist, stick, cream, gel, and aerosol spray. Of these, roll-on or mist is preferred.
- the unit of the blending amount is “% by mass” unless otherwise specified.
- Examples 1 to 11 and Comparative Examples 1 to 3 Each component shown in the following Table 1 was blended in the blending amount (content, unit is mass%) shown in the following Table 1, and mixed with a disper mixer to obtain a deodorant composition.
- the above-mentioned viscosity ⁇ of the obtained deodorant composition was 10 mPa ⁇ s or more and 3000 mPa ⁇ s or less.
- the obtained deodorant composition was filled in a roll-on container to obtain a deodorant agent.
- the artificial sweat was prepared according to JIS L0848: 2004. Specifically, 0.5 g of L-histidine hydrochloride monohydrate, 5 g of sodium chloride, and 2.2 g of sodium dihydrogen phosphate dihydrate were dissolved in water, and then 0.1 mol / L sodium hydroxide. Water was added to 15 mL and the total amount was 1 L to prepare acidic artificial sweat. The acidic artificial sweat thus obtained had a pH of 5.5.
- the keratin cloth after shaking was put into the centrifuge tube and shaken at 150 rpm for 10 minutes. Thereafter, the liquid in the centrifuge tube was filtered with a 0.45 ⁇ m membrane filter.
- the amount (Y) of the bactericide in the liquid after filtration was evaluated by HPLC.
- an evaluation sample in which 20 ⁇ L of the obtained deodorant composition was applied to a keratin cloth was prepared separately, and the disinfectant in the liquid after filtration when subjected to the same treatment without shaking in acidic artificial sweat
- the amount (X) was evaluated. Based on the amount (X) of the bactericide, the residual rate of the bactericide ((Y) / (X) ⁇ 100%) was determined.
- Example 12 and Comparative Example 4 Each component shown in the following Table 2 was blended in the blending amount (content, unit is mass%) shown in the following Table 2, and mixed with a disper mixer to obtain a deodorant composition.
- the above-mentioned viscosity ⁇ of the obtained deodorant composition was 10 mPa ⁇ s or more and 3000 mPa ⁇ s or less.
- Example 12 About 0.2 g of the deodorant composition of Example 12 was applied to one eyelid of each subject, and about 0.2 g of the deodorant composition of Comparative Example 4 was applied to the other eyelid.
- each bag was wiped three times with a cloth impregnated with 99% ethanol. Subsequently, the disinfectant components (isopropylmethylphenol and benzalkonium chloride) in each cloth were extracted with 60% methanol, and the extracted amount was analyzed using high performance liquid chromatography (HPLC).
- HPLC high performance liquid chromatography
- the average value of all subjects extracted from the soot coated with the deodorant composition of Example 12 was (I1), and the isopropyl methylphenol obtained from the soot coated with the deodorant composition of Comparative Example 4 was used.
- the average value of all the subjects in the extracted amount was defined as (I2).
- the average value of all subjects in the amount of benzalkonium chloride extracted from the soot coated with the deodorant composition of Example 12 is (B1), and the benzil chloride obtained from the soot coated with the deodorant composition of Comparative Example 4 is used.
- the average value of all subjects for the extracted amount of ruthenium was defined as (B2).
- the value [(I1) / (I2)] obtained by dividing (I1) by (I2) is about 3.3, and the value [(B1) / (B2)] obtained by dividing (B1) by (B2) is about 1.5. Therefore, compared with the deodorant composition of Comparative Example 4, in the deodorant composition of Example 12, the residual amount of isopropylmethylphenol after about 8 hours of application was about 3.3 times, and the residual amount of benzalkonium chloride was It was about 1.5 times, and it was found that the deodorant composition of Example 12 was excellent in the persistence of the disinfectant in the composition.
- Evaluation was performed with 7 male subjects. Each subject evaluated after washing their body.
- Example 12 About 0.2 g of the deodorant composition of Example 12 was applied to one eyelid (referred to as “application side eyelid”) of each subject, and what was applied to the other eyelid (referred to as “unapplied side eyelid”). Was not applied.
- the wrinkle on the application side was weaker in odor by the Wilcoxson signed rank sum test than the wrinkle on the non-application side (the score was small). Therefore, the deodorant effect of the deodorant composition of Example 12 was maintained even after 24 hours, and the deodorant composition of Example 12 was found to have excellent deodorant effect persistence.
- Evaluation of persistence of bactericidal effect Evaluation was performed with 7 male subjects. Each subject evaluated after washing their body.
- Example 12 About 0.2 g of the deodorant composition of Example 12 was applied to one eyelid (referred to as “application side eyelid”) of each subject, and what was applied to the other eyelid (referred to as “unapplied side eyelid”). Was not applied.
- the coating side wrinkles and the uncoated side wrinkles were compared by the following ATP (adenosine triphosphate) wiping test.
- the bacteria collected from the sputum on the application side are extracted with physiological saline, the physiological saline is used as the “application-side sample”, the bacteria collected from the sputum on the non-application side are extracted with physiological saline, and the physiological saline is The sample was “uncoated sample”.
- the ATP emission amount of the coated sample was about 400 (unit: RLU), and the ATP emission amount of the uncoated sample was about 18200 (unit: RLU).
- said ATP light-emission amount is large means that there are many microbes.
- the bactericidal effect of the deodorant composition of Example 12 was maintained even after 24 hours, and it was found that the deodorant composition of Example 12 had an excellent bactericidal effect.
- Examples 13 to 21 Each component shown in the following Table 3 was blended in the blending amount (content, unit is mass%) shown in the following Table 3, and mixed with a disper mixer to obtain a deodorant composition.
- the above-mentioned viscosity ⁇ of the obtained deodorant composition was 10 mPa ⁇ s or more and 3000 mPa ⁇ s or less.
- (Formulation example 2) Deodorant mist ethanol 60.0 mass% Benzalkonium chloride 0.1% by mass Triclosan 0.2% by mass Stearoxyhydroxypropylmethylcellulose 0.8 mass% Glyceryl tri-2-ethylhexanoate 2.0% by mass Polyoxyethylene polyoxypropylene decyl tetradecyl ether 1.0% by mass Zinc paraphenolsulfonate 0.3% by mass Hydroxypropyl cellulose 0.3% by mass Polyethylene glycol 400 2.0% by mass l-Menthol 0.3% by mass l-Mentylglyceryl ether 0.2% by mass Plant extract 0.1% by mass Purified water balance 100.0% by mass
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Cosmetics (AREA)
Abstract
Description
本発明に係るデオドラント組成物における(A)エタノールの含有量は特に限定されない。上記デオドラント組成物100質量%中、(A)エタノールの含有量は好ましくは20.0質量%以上、より好ましくは40.0質量%以上、更に好ましくは50.0質量%を超え、特に好ましくは60.0質量%以上、好ましくは99.5質量%以下、より好ましくは95.5質量%以下、更に好ましくは90.0質量%以下、特に好ましくは89.0質量%以下、最も好ましくは80.0質量%以下である。(A)エタノールの含有量が上記下限以上であると、使用性及び速乾性がより一層高くなる。(A)エタノールの含有量の上限は他の成分の含有量に応じて適宜調整可能である。
本発明に係るデオドラント組成物に含まれる(B)殺菌剤は、殺菌作用を有する。本発明では、塗布後の殺菌剤の残存性、及び塗布後の殺菌効果の持続性にかなり優れている。
本発明に係るデオドラント組成物に含まれる(C)疎水化ヒドロキシアルキルセルロースは、ヒドロキシアルキルセルロースの疎水化物である。(C)疎水化ヒドロキシアルキルセルロースは特に限定されない。(C)疎水化ヒドロキシアルキルセルロースとしては、例えば、疎水化ヒドロキシプロピルメチルセルロース及び疎水化ヒドロキシエチルセルロース等が挙げられる。(C)疎水化ヒドロキシアルキルセルロースは、1種のみが用いられてもよく、2種以上が用いられてもよい。
本発明に係るデオドラント組成物に含まれる(D)エステル化合物の分子量は150以上である。(D)エステル化合物の分子量が上記下限以上であることにより、塗布後の殺菌剤の残存性、及び塗布後の殺菌効果の持続性が効果的に高くなる。(D)エステル化合物は、1種のみが用いられてもよく、2種以上が用いられてもよい。
本発明に係るデオドラント組成物は、(E)ノニオン性界面活性剤を含むことが好ましい。(E)ノニオン性界面活性剤は、(D)エステル化合物の可溶化剤としても作用し、(D)エステル化合物の添加効果をより一層高める役割を果たす。
本発明に係るデオドラント組成物は、(F)制汗剤を含んでもよい。(F)制汗剤は、例えば、皮膚を収れんすることにより、汗の発生を抑制する。(F)制汗剤は特に限定されない。(F)制汗剤としては、従来公知の制汗剤が挙げられる。(F)制汗剤は、1種のみが用いられてもよく、2種以上が用いられてもよい。
本発明に係るデオドラント組成物は、水を含むことが好ましい。上記水は、特に限定されないが、精製水であることが好ましい。上記デオドラント組成物が水を含むことにより、(C)疎水化ヒドロキシアルキルセルロースが膨潤して、より一層効果が発現しやすくなる。
本発明に係るデオドラント組成物は、増粘剤を含んでいてもよい。上記増粘剤としては、水溶性高分子等が挙げられる。上記増粘剤の具体例としては、ヒドロキシアルキルセルロース等が挙げられる。上記ヒドロキシアルキルセルロースとしては、ヒドロキシメチルセルロース、ヒドロキシエチルセルロース、ヒドロキシプロピルセルロース及びヒドロキシプロピルメチルセルロース等が挙げられる。上記増粘剤は、1種のみが用いられてもよく、2種以上が用いられてもよい。
本発明に係るデオドラント組成物の25℃における粘度ηは、特に限定されないが、容器からのデオドラント組成物の吐出性及び塗布性を良好にする観点から、好ましくは10mPa・s以上、より好ましくは50mPa・s以上、好ましくは5000mPa・s以下、より好ましくは3000mPa・s以下である。
本発明に係るデオドラント剤は、容器と、該容器内に充填されている上記デオドラント組成物とを備える。
エタノール
((B)殺菌剤)
イソプロピルメチルフェノール
塩化ベンザルコニウム
((C)疎水化ヒドロキシアルキルセルロース)
ステアロキシヒドロキシプロピルメチルセルロース(大同化成工業株式会社製「サンジェロース60M」)
((D)エステル化合物)
トリ2-エチルヘキサン酸グリセリル(分子量470、logP値8.919)
アジピン酸ジイソプロピル(分子量230、logP値2.676)
アジピン酸ジイソブチル(分子量258、logP値3.17)
ミリスチン酸ポリプロピレングリコール-3ベンジルエーテル(分子量548)
イソノナン酸イソノニル(分子量284、logP値7.098)
ミリスチン酸イソプロピル(分子量270、logP値7.43±0.21)
イソステアリン酸プロピレングリコール(分子量342、logP値7.826)
パルミチン酸イソプロピル(分子量298、logP値8.49±0.21)
パルミチン酸2-エチルヘキシル(分子量368、logP値8.93)
テトラオクタン酸ペンタエリスリチル(分子量640、logP値12.076)
ミリスチン酸オクチルドデシル(分子量508、logP値15.914)
((E)ノニオン性界面活性剤)
ポリオキシエチレンポリオキシプロピレンデシルテトラデシルエーテル(日本サーファクタント工業株式会社製「PEN-4620」)
((F)制汗剤)
クロルヒドロキシアルミニウム
(水)
精製水
(他の成分)
ヒドロキシプロピルセルロース
ポリエチレングリコール400
下記の表1に示す各成分を下記の表1に示す配合量(含有量、単位は質量%)で配合し、ディスパーミキサーで混合して、デオドラント組成物を得た。得られたデオドラント組成物の上記粘度ηはいずれも、10mPa・s以上、3000mPa・s以下であった。
JIS L0848:2004に準じて、人口汗を調製した。具体的には、L-ヒスチジン塩酸塩一水和物0.5g、塩化ナトリウム5g、及びりん酸ニ水素ナトリウム二水和物2.2gを水に溶かし、次に0.1mol/L水酸化ナトリウム15mLと全量が1Lとなるように水とを加えて、酸性人口汗を調製した。得られた酸性人口汗のpHは5.5であった。
下記の表2に示す各成分を下記の表2に示す配合量(含有量、単位は質量%)で配合し、ディスパーミキサーで混合して、デオドラント組成物を得た。得られたデオドラント組成物の上記粘度ηはいずれも、10mPa・s以上、3000mPa・s以下であった。
男性被験者3名にて評価を行った。
(I1)を(I2)で除した値[(I1)/(I2)]は約3.3であり、(B1)を(B2)で除した値[(B1)/(B2)]は約1.5であった。従って、比較例4のデオドラント組成物と比べて、実施例12のデオドラント組成物では、塗布8時間後のイソプロピルメチルフェノールの残存量が約3.3倍であり、塩化ベンザルコニウムの残存量が約1.5倍であり、実施例12のデオドラント組成物は、組成物中の殺菌剤の残存性に優れていることがわかった。
男性被験者7名にて評価を行った。各被験者は体を洗浄した後に評価を行った。
0点:無臭
1点:やっと感知できる程度の臭い
2点:何の臭いであるかがわかる程度の臭い
3点:楽に感知できる程度の臭い
4点:強い臭い
5点:強烈な臭い
男性被験者7名にて評価を行った。各被験者は体を洗浄した後に評価を行った。
塗布の24時間後、綿棒で腋を拭き取り、菌を採取した。塗布側の腋から採取した菌を生理食塩水で抽出し、該生理食塩水を「塗布側サンプル」とし、未塗布側の腋から採取した菌を生理食塩水で抽出し、該生理食塩水を「未塗布側サンプル」とした。塗布側サンプル、及び未塗布側サンプルに、それぞれATP抽出試薬、ATP発光試薬を添加した後、ATP測定器(キッコーマンバイオケミファ株式会社製、「ルミテスターC-110」により発光量を測定した。
下記の表3に示す各成分を下記の表3に示す配合量(含有量、単位は質量%)で配合し、ディスパーミキサーで混合して、デオドラント組成物を得た。得られたデオドラント組成物の上記粘度ηはいずれも、10mPa・s以上、3000mPa・s以下であった。
エタノール 60.0質量%
イソプロピルメチルフェノール 0.1質量%
トリクロサン 0.2質量%
ステアロキシヒドロキシプロピルメチルセルロース 0.8質量%
トリ2-エチルヘキサン酸グリセリル 2.0質量%
ポリオキシエチレンポリオキシプロピレンデシルテトラデシルエーテル
1.0質量%
パラフェノールスルホン酸亜鉛 0.3質量%
ヒドロキシプロピルセルロース 0.3質量%
ポリエチレングリコール400 2.0質量%
l-メントール 0.4質量%
精製水 残部
合計 100.0質量%
エタノール 60.0質量%
塩化ベンザルコニウム 0.1質量%
トリクロサン 0.2質量%
ステアロキシヒドロキシプロピルメチルセルロース 0.8質量%
トリ2-エチルヘキサン酸グリセリル 2.0質量%
ポリオキシエチレンポリオキシプロピレンデシルテトラデシルエーテル
1.0質量%
パラフェノールスルホン酸亜鉛 0.3質量%
ヒドロキシプロピルセルロース 0.3質量%
ポリエチレングリコール400 2.0質量%
l-メントール 0.3質量%
l-メンチルグリセリルエーテル 0.2質量%
植物エキス 0.1質量%
精製水 残部
合計 100.0質量%
エタノール 50.0質量%
イソプロピルメチルフェノール 0.1質量%
塩化ベンザルコニウム 0.1質量%
ステアロキシヒドロキシプロピルメチルセルロース 0.8質量%
トリ2-エチルヘキサン酸グリセリル 2.0質量%
ポリオキシエチレンポリオキシプロピレンデシルテトラデシルエーテル
1.0質量%
クロルヒドロキシアルミニウム 5.0質量%
ヒドロキシプロピルセルロース 0.3質量%
ポリエチレングリコール400 2.0質量%
架橋ポリスチレン 2.0質量%
精製水 残部
合計 100.0質量%
エタノール 50.0質量%
イソプロピルメチルフェノール 0.1質量%
塩化ベンザルコニウム 0.1質量%
ステアロキシヒドロキシプロピルメチルセルロース 0.2質量%
トリ2-エチルヘキサン酸グリセリル 1.0質量%
ポリオキシエチレンポリオキシプロピレンデシルテトラデシルエーテル
1.0質量%
パラフェノールスルホン酸亜鉛 0.3質量%
ヒドロキシプロピルセルロース 0.1質量%
l-メントール 0.5質量%
l-メンチルグリセリルエーテル 0.1質量%
香料 0.3質量%
植物エキス 0.1質量%
精製水 残部
合計 100.0質量%
エタノール 50.0質量%
イソプロピルメチルフェノール 0.1質量%
塩化ベンザルコニウム 0.1質量%
ステアロキシヒドロキシプロピルメチルセルロース 0.2質量%
トリ2-エチルヘキサン酸グリセリル 1.0質量%
ポリオキシエチレンポリオキシプロピレンデシルテトラデシルエーテル
1.0質量%
パラフェノールスルホン酸亜鉛 0.3質量%
ヒドロキシプロピルセルロース 0.1質量%
ナイロン末 1.0質量%
架橋ポリスチレン 1.0質量%
l-メントール 0.2質量%
l-メンチルグリセリルエーテル 0.1質量%
香料 0.2質量%
精製水 残部
合計 100.0質量%
Claims (9)
- エタノールと、殺菌剤と、疎水化ヒドロキシアルキルセルロースと、分子量が150以上であるエステル化合物とを含む、デオドラント組成物。
- 前記エステル化合物のlogP値が1以上、40以下である、請求項1に記載のデオドラント組成物。
- 前記エステル化合物が、イソノナン酸イソノニル、トリ2-エチルヘキサン酸グリセリル、アジピン酸ジイソプロピル、アジピン酸ジイソブチル、ミリスチン酸ポリプロピレングリコール-3ベンジルエーテル、ミリスチン酸イソプロピル、イソステアリン酸プロピレングリコール、パルミチン酸イソプロピル、パルミチン酸2-エチルヘキシル、2-エチルヘキサン酸セチル、テトラオクタン酸ペンタエリスリチル、ミリスチン酸オクチルドデシル、及びテトライソステアリン酸ペンタエリトリットからなる群から選択されるエステル化合物である、請求項1に記載のデオドラント組成物。
- 前記殺菌剤が、イソプロピルメチルフェノール、塩化ベンザルコニウム、ヒノキチオール、トリクロサン、及びサリチル酸からなる群から選択される殺菌剤である、請求項1~3のいずれか1項に記載のデオドラント組成物。
- ノニオン性界面活性剤を含む、請求項1~4のいずれか1項に記載のデオドラント組成物。
- 制汗剤を含む、請求項1~5のいずれか1項に記載のデオドラント組成物。
- 前記制汗剤が、クロルヒドロキシアルミニウム、パラフェノールスルホン酸亜鉛及びミョウバンからなる群から選択される制汗剤である、請求項6に記載のデオドラント組成物。
- 容器と、請求項1~7のいずれか1項に記載のデオドラント組成物とを備え、
前記デオドラント組成物が、前記容器内に充填されている、デオドラント剤。 - 非エアゾール製剤である、請求項8に記載のデオドラント剤。
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP15769659.2A EP3124012A4 (en) | 2014-03-26 | 2015-02-20 | Deodorant composition and deodorant agent |
CN201580001511.8A CN105473124A (zh) | 2014-03-26 | 2015-02-20 | 除臭组合物和除臭剂 |
JP2016510134A JP6125718B2 (ja) | 2014-03-26 | 2015-02-20 | デオドラント組成物及びデオドラント剤 |
US14/904,066 US20160166491A1 (en) | 2014-03-26 | 2015-02-20 | Deodorant composition and deodorant agent |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2014063891 | 2014-03-26 | ||
JP2014-063891 | 2014-03-26 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2015146398A1 true WO2015146398A1 (ja) | 2015-10-01 |
Family
ID=54194933
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2015/054802 WO2015146398A1 (ja) | 2014-03-26 | 2015-02-20 | デオドラント組成物及びデオドラント剤 |
Country Status (5)
Country | Link |
---|---|
US (1) | US20160166491A1 (ja) |
EP (1) | EP3124012A4 (ja) |
JP (1) | JP6125718B2 (ja) |
CN (1) | CN105473124A (ja) |
WO (1) | WO2015146398A1 (ja) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2019151567A (ja) * | 2018-03-01 | 2019-09-12 | 花王株式会社 | ミスト化粧料 |
JP2019156815A (ja) * | 2018-03-16 | 2019-09-19 | 株式会社マンダム | 制汗剤組成物、及び制汗剤 |
JP2019156813A (ja) * | 2018-03-16 | 2019-09-19 | 株式会社マンダム | 制汗剤組成物、及び制汗剤 |
WO2019176265A1 (ja) * | 2018-03-16 | 2019-09-19 | 株式会社マンダム | 制汗剤組成物、及び制汗剤 |
JP2020066612A (ja) * | 2018-10-26 | 2020-04-30 | ライオン株式会社 | 制汗剤組成物 |
JP2020147537A (ja) * | 2019-03-14 | 2020-09-17 | 株式会社マンダム | 皮膚外用剤組成物 |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2719380C1 (ru) | 2016-12-14 | 2020-04-17 | Колгейт-Палмолив Компани | Композиции антиперспиранта/дезодоранта, не содержащие алюминия |
CN110279789A (zh) * | 2019-07-09 | 2019-09-27 | 许富明 | 一种祛狐臭活性剂及其制备方法 |
CN111821841A (zh) * | 2020-07-31 | 2020-10-27 | 武汉世纪瑞科环保科技有限公司 | 一种垃圾除臭剂及其制备方法 |
CN113622194A (zh) * | 2021-08-12 | 2021-11-09 | 安徽高梵电子商务有限公司 | 一种基于羽绒服饰的蒸汽除味方法 |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2004285052A (ja) * | 2003-03-06 | 2004-10-14 | Lion Corp | 化粧料組成物 |
JP2008110992A (ja) * | 2008-01-29 | 2008-05-15 | Mandom Corp | 抗菌性組成物及び皮膚外用剤 |
JP2012092078A (ja) * | 2010-10-29 | 2012-05-17 | Nippon Fine Chem Co Ltd | ヒドロキシニコチン酸又はその誘導体を含有する化粧料又は皮膚外用剤 |
JP2013203701A (ja) * | 2012-03-28 | 2013-10-07 | Mandom Corp | ジケトン作用抑制剤 |
JP2013203700A (ja) * | 2012-03-28 | 2013-10-07 | Mandom Corp | 体臭抑制剤 |
JP2014028778A (ja) * | 2012-07-31 | 2014-02-13 | Mandom Corp | ジケトン作用抑制剤 |
JP2014070022A (ja) * | 2012-09-27 | 2014-04-21 | Mandom Corp | デオドラント組成物及びデオドラント剤 |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1195486C (zh) * | 1999-07-26 | 2005-04-06 | 花王株式会社 | 除臭剂 |
JP2004143104A (ja) * | 2002-10-25 | 2004-05-20 | Shiseido Co Ltd | 皮膚外用剤 |
US7892525B2 (en) * | 2003-08-22 | 2011-02-22 | Lubrizol Advanced Materials, Inc. | Antiperspirant gel compositions |
JP4332062B2 (ja) * | 2004-04-23 | 2009-09-16 | 株式会社コーセー | 油中水型美白化粧料 |
CN101119703A (zh) * | 2004-12-16 | 2008-02-06 | 赫尔克里士公司 | 疏水改性的多糖的个人护理和家用组合物 |
DE102005029386A1 (de) * | 2005-06-23 | 2007-01-11 | Beiersdorf Ag | Wirkstoffkombinationen aus Glycopyrroniumbromid und einem oder mehreren Hydrokolloiden |
CA2623591A1 (en) * | 2005-09-13 | 2007-03-22 | Basf Se | Microorganisms inhibiting the formation of axillary malodor |
EP2228052A1 (en) * | 2009-03-09 | 2010-09-15 | Coty Deutschland GmbH | Cosmetic basic composition and use thereof |
BRPI1014529A2 (pt) * | 2009-03-20 | 2015-08-25 | Stiefel Laboratories | Composições de monoglicerídeo de ácido graxo |
WO2009087242A2 (en) * | 2009-04-09 | 2009-07-16 | Symrise Gmbh & Co. Kg | Compositions comprising trans-tert-butyl cyclohexanol as skin irritation-reducing agent |
EP2482790B1 (en) * | 2009-09-30 | 2017-09-27 | Colgate-Palmolive Company | Antiperspirant composition |
JP5813962B2 (ja) * | 2011-02-17 | 2015-11-17 | 株式会社コーセー | 油性目元用下地化粧料 |
JP5859738B2 (ja) * | 2011-03-31 | 2016-02-16 | 株式会社コーセー | 固形粉末化粧料 |
JP5895478B2 (ja) * | 2011-11-29 | 2016-03-30 | ライオン株式会社 | 液体制汗デオドラント組成物及び液体制汗デオドラント製品 |
-
2015
- 2015-02-20 CN CN201580001511.8A patent/CN105473124A/zh active Pending
- 2015-02-20 WO PCT/JP2015/054802 patent/WO2015146398A1/ja active Application Filing
- 2015-02-20 EP EP15769659.2A patent/EP3124012A4/en not_active Withdrawn
- 2015-02-20 JP JP2016510134A patent/JP6125718B2/ja active Active
- 2015-02-20 US US14/904,066 patent/US20160166491A1/en not_active Abandoned
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2004285052A (ja) * | 2003-03-06 | 2004-10-14 | Lion Corp | 化粧料組成物 |
JP2008110992A (ja) * | 2008-01-29 | 2008-05-15 | Mandom Corp | 抗菌性組成物及び皮膚外用剤 |
JP2012092078A (ja) * | 2010-10-29 | 2012-05-17 | Nippon Fine Chem Co Ltd | ヒドロキシニコチン酸又はその誘導体を含有する化粧料又は皮膚外用剤 |
JP2013203701A (ja) * | 2012-03-28 | 2013-10-07 | Mandom Corp | ジケトン作用抑制剤 |
JP2013203700A (ja) * | 2012-03-28 | 2013-10-07 | Mandom Corp | 体臭抑制剤 |
JP2014028778A (ja) * | 2012-07-31 | 2014-02-13 | Mandom Corp | ジケトン作用抑制剤 |
JP2014070022A (ja) * | 2012-09-27 | 2014-04-21 | Mandom Corp | デオドラント組成物及びデオドラント剤 |
Non-Patent Citations (3)
Title |
---|
DENNIS R.JENKE: "LIQUID CHROMATOGRAPHIC ESTIMATION OF OCTANOL/WATER PARTITION COEFFICIENTS WITH A HIGH EFFICIENCY, NONPOROUS, ULTRASMALL PARTICLE SIZE REVERSE PHASE STATIONARY PHASE", JOURNAL OF LIQUID CHROMATOGRAPHY & RELATED TECHNOLOGIES, vol. 19, no. 14, 1996, pages 2227 - 2245, XP008179217 * |
See also references of EP3124012A4 * |
YASUNARI INAMOTO: "Iyakuhin Keshohin Tenkabutsu to shite no Sangelose", PHARM TECH JAPAN, vol. 27, no. 12, 1 November 2011 (2011-11-01), pages 2377 - 2379, XP008179194 * |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2019151567A (ja) * | 2018-03-01 | 2019-09-12 | 花王株式会社 | ミスト化粧料 |
JP7256602B2 (ja) | 2018-03-01 | 2023-04-12 | 花王株式会社 | ミスト化粧料 |
JP2019156815A (ja) * | 2018-03-16 | 2019-09-19 | 株式会社マンダム | 制汗剤組成物、及び制汗剤 |
JP2019156813A (ja) * | 2018-03-16 | 2019-09-19 | 株式会社マンダム | 制汗剤組成物、及び制汗剤 |
WO2019176265A1 (ja) * | 2018-03-16 | 2019-09-19 | 株式会社マンダム | 制汗剤組成物、及び制汗剤 |
JP2020066612A (ja) * | 2018-10-26 | 2020-04-30 | ライオン株式会社 | 制汗剤組成物 |
JP7101097B2 (ja) | 2018-10-26 | 2022-07-14 | ライオン株式会社 | 制汗剤組成物 |
JP2020147537A (ja) * | 2019-03-14 | 2020-09-17 | 株式会社マンダム | 皮膚外用剤組成物 |
JP7261046B2 (ja) | 2019-03-14 | 2023-04-19 | 株式会社マンダム | シート化粧料 |
Also Published As
Publication number | Publication date |
---|---|
US20160166491A1 (en) | 2016-06-16 |
EP3124012A4 (en) | 2017-09-06 |
JPWO2015146398A1 (ja) | 2017-04-13 |
EP3124012A1 (en) | 2017-02-01 |
JP6125718B2 (ja) | 2017-05-10 |
CN105473124A (zh) | 2016-04-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6125718B2 (ja) | デオドラント組成物及びデオドラント剤 | |
JP5965803B2 (ja) | デオドラント組成物及びデオドラント剤 | |
KR101189344B1 (ko) | 자가-보존성 스킨케어 조성물 | |
JP2007016045A (ja) | ローズマリー抽出物およびdhaを含有する化粧品組成物 | |
JP5895478B2 (ja) | 液体制汗デオドラント組成物及び液体制汗デオドラント製品 | |
JP6830629B2 (ja) | 消毒用組成物 | |
JP2006028084A (ja) | デオドラント剤および製剤 | |
JP6900122B2 (ja) | 制汗剤組成物、及び制汗剤 | |
ES2924128T3 (es) | Productos desodorantes | |
US6010687A (en) | Deodorant composition | |
JP4688579B2 (ja) | 頭皮用組成物 | |
JP2002370958A (ja) | 液状化粧料 | |
JP6900121B2 (ja) | 制汗剤組成物、及び制汗剤 | |
JP3479048B2 (ja) | 化粧料及び不織布含浸化粧料 | |
JP5025535B2 (ja) | 抗菌剤組成物及び防臭剤用組成物 | |
JP2010116376A (ja) | 化粧料 | |
JP2011246398A (ja) | 容器入り水系組成物 | |
WO2019151275A1 (ja) | アデノシンリン酸含有組成物のべたつき改善方法 | |
JP6613123B2 (ja) | 制汗デオドラント組成物 | |
JP7475785B2 (ja) | 水中油型乳化組成物 | |
JP6284437B2 (ja) | 体臭抑制剤 | |
JP6405396B2 (ja) | 口腔用組成物 | |
WO2023276203A1 (ja) | 使用感を改善したアルコール系擦り込み式手指消毒組成物 | |
FR3121844A1 (fr) | Déodorants ou antitranspirants limpides et doux pour la peau | |
JP2009190986A (ja) | 透明ジェル化粧料 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 201580001511.8 Country of ref document: CN |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 15769659 Country of ref document: EP Kind code of ref document: A1 |
|
ENP | Entry into the national phase |
Ref document number: 2016510134 Country of ref document: JP Kind code of ref document: A |
|
REEP | Request for entry into the european phase |
Ref document number: 2015769659 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2015769659 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 14904066 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: IDP00201601123 Country of ref document: ID |
|
NENP | Non-entry into the national phase |
Ref country code: DE |